PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.01
0.01
년간 변동
0.01
1.35
일일 변동
-99.03%
월간 변동
-99.08%
6달 변화
-99.07%
년간 변동율
-99.07%
이전 종가
1.1 4
Open
0.0 1
저가
0.0 1
High
0.0 1
양
5
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 202020212022202320242025 TTM

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

뉴스